Traphaco JSC (VN:TRA) — Market Cap & Net Worth
Market Cap & Net Worth: Traphaco JSC (TRA)
Traphaco JSC (VN:TRA) has a market capitalization of $58.27 Million (₫1.53 Trillion) as of September 24, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #21429 globally and #159 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Traphaco JSC's stock price ₫37000.00 by its total outstanding shares 41450540 (41.45 Million). Also see Traphaco JSC asset portfolio for a full breakdown of the balance sheet.
Traphaco JSC Market Cap History: 2015 to 2026
Traphaco JSC's market capitalization history from 2015 to 2026. Data shows growth from $58.91 Million to $58.27 Million (0.49% CAGR). Also see Traphaco JSC (TRA) cash flow conversion for how efficiently the company converts equity into cash flow.
Traphaco JSC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Traphaco JSC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check TRA share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Traphaco JSC's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Traphaco JSC's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $77.33 Million | $1.71 Trillion | $153.43 Billion | 0.00x | 0.00x |
| 2020 | $96.32 Million | $1.91 Trillion | $195.79 Billion | 0.00x | 0.00x |
| 2021 | $128.14 Million | $2.16 Trillion | $241.59 Billion | 0.00x | 0.00x |
| 2022 | $132.11 Million | $2.40 Trillion | $269.14 Billion | 0.00x | 0.00x |
| 2023 | $133.58 Million | $2.30 Trillion | $263.25 Billion | 0.00x | 0.00x |
| 2024 | $123.63 Million | $2.35 Trillion | $239.02 Billion | 0.00x | 0.00x |
| 2025 | $118.12 Million | $2.66 Trillion | $249.65 Billion | 0.00x | 0.00x |
Competitor Companies of TRA by Market Capitalization
Companies near Traphaco JSC in the global market cap rankings as of September 24, 2026. Review Traphaco JSC tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Traphaco JSC by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #651 globally with a market cap of $42.68 Billion USD ( CN¥291.65 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #524 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #586 | GALDERMA GROUP AG | NYSE:GALDY | $46.44 Billion | $39.83 |
| #638 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.50 |
| #651 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $42.68 Billion | CN¥45.72 |
Traphaco JSC Historical Marketcap From 2015 to 2026
Between 2015 and today, Traphaco JSC's market cap moved from $58.91 Million to $ 58.27 Million, with a yearly change of 0.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₫58.27 Million | -50.67% |
| 2025 | ₫118.12 Million | -4.46% |
| 2024 | ₫123.63 Million | -7.45% |
| 2023 | ₫133.58 Million | +1.11% |
| 2022 | ₫132.11 Million | +3.10% |
| 2021 | ₫128.14 Million | +33.04% |
| 2020 | ₫96.32 Million | +24.56% |
| 2019 | ₫77.33 Million | -9.71% |
| 2018 | ₫85.65 Million | -39.46% |
| 2017 | ₫141.47 Million | +28.78% |
| 2016 | ₫109.85 Million | +86.48% |
| 2015 | ₫58.91 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Traphaco JSC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $58.27 Million USD |
| MoneyControl | $58.27 Million USD |
| MarketWatch | $58.27 Million USD |
| marketcap.company | $58.27 Million USD |
| Reuters | $58.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Traphaco JSC
Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases,… Read more